<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://elea.unisa.it/xmlui/handle/10556/1546">
<title>Translational Medicine @ UniSa. Volume 10 (sept.-dec. 2014)</title>
<link>http://elea.unisa.it/xmlui/handle/10556/1546</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://elea.unisa.it/xmlui/handle/10556/1642"/>
<rdf:li rdf:resource="http://elea.unisa.it/xmlui/handle/10556/1641"/>
<rdf:li rdf:resource="http://elea.unisa.it/xmlui/handle/10556/1640"/>
<rdf:li rdf:resource="http://elea.unisa.it/xmlui/handle/10556/1639"/>
</rdf:Seq>
</items>
<dc:date>2026-04-20T11:33:11Z</dc:date>
</channel>
<item rdf:about="http://elea.unisa.it/xmlui/handle/10556/1642">
<title>Osteitis pubis: can early return to elite competition be contemplated?</title>
<link>http://elea.unisa.it/xmlui/handle/10556/1642</link>
<description>Osteitis pubis: can early return to elite competition be contemplated?
Background and purpose
In elite athletes, osteitis pubis is a common painful degenerative process of the pubic symphysis and surrounding soft tissues and tendons. We report the diagnostic pathway and the rehabilitation protocol of six elite athletes with osteitis pubis in three different sports, and compare protocol stages and time to return to competition.
Methods 6 athletes (2 soccer, 2 basketball, 2 rugby players) were diagnosed with osteitis pubis stage III and IV according to Rodriguez classification using standard clinical and imaging criteria. After performing a baseline lumbo-pelvic assessment, the rehabilitation protocol described by Verrall was adapted to each individual athlete.
Results The length of time for each stage of the protocol was as follows; Stage 1 (rest from sport) was 26 +/- 5 days, Stage 2 (to achieve pain free running), 18 +/- 5 days, Stage 3 (squad training) 63 +/- 7, Stage 4 (return to competition) 86 +/- 15. Soccer players took longer to return to competition than basketball and rugby players. No recurrences were reported at 2 year follow-up.
Conclusion The protocol presented ensures a safe return to elite athletes. The time from diagnosis to full recovery is longer in football players, and seems to increase with age.
</description>
<dc:date>2014-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://elea.unisa.it/xmlui/handle/10556/1641">
<title>Assessment of the effectiveness of extracorporeal shock wave therapy (ESWT) for soft tissue injuries (assert): an online database protocol</title>
<link>http://elea.unisa.it/xmlui/handle/10556/1641</link>
<description>Assessment of the effectiveness of extracorporeal shock wave therapy (ESWT) for soft tissue injuries (assert): an online database protocol
Maffulli, G.; Hemmings, Steph; Maffulli, Nicola
Background Soft tissue injuries and tendinopathies account for large numbers of chronic musculoskeletal disorders. Extracorporeal shockwave therapy (ESWT) is popular, and effective in the management of chronic tendon conditions in the elbow, shoulder, and pain at and around the heel.
Methods/Design
Ethical approval was granted from the South East London Research Ethics Committee to implement a database for the Assessment of Effectiveness of Extracorporeal Shock Wave Therapy for Soft Tissue Injuries (ASSERT) to prospectively collect information on the effectiveness of ESWT across the UK. All participants will give informed consent. All clinicians follow a standardised method of administration of the ESWT. The primary outcome measures are validated outcome measures specific to the condition being treated. A Visual Analogue Score for pain and the EuroQol will be completed alongside the condition specific outcome tool at baseline, 3, 6, 12 and 24 months post treatment.
Discussion
The development of the ASSERT database will enable the evaluation of the effectiveness of ESWT for patients suffering from chronic conditions (plantar fasciopathy, tennis elbow, Achilles tendinopathy, greater trochanter pain syndrome and patellar tendinopathy). The results will aid the clinicians in the decision making process when managing these patients.
</description>
<dc:date>2014-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://elea.unisa.it/xmlui/handle/10556/1640">
<title>Lifestyle and eating habits in a business community</title>
<link>http://elea.unisa.it/xmlui/handle/10556/1640</link>
<description>Lifestyle and eating habits in a business community
PURPOSE: The present study verified, using a validated questionnaire, the presence of unhealthy aspects of lifestyle and chronic degenerative conditions in a working community.
METHODS: A cohort from a working community in Italy was investigated using of the INRAN (Istituto Nazionale di Ricerca per gli Alimenti e Nutrizione) questionnaire dedicated to the eating habits and Physical Activity Stages of Change. RESULTS: Most of the 93 subjects (56 females and 37 males, aged 42.0±0.7) recruited reported low levels of physical activity (70 subjects). Slightly more than 50% of the subjects undertook physical activity more than once a week, while 13% did it only once. Food intolerances were reported by 7 subjects (8%), with a high consumption of fruits, cereals and dairy products, low consumption of fish and alcohol, and meat consumption in the normal range. There was a high satisfaction in general quality of life. CONCLUSION: Questionnaire investigations play a role to identify the presence of degenerative chronic conditions in working communities. The self-reported perception of quality of life does not necessarily agree with the lifestyle habits found. Awareness of this aspect could be helpful to plan lifestyle interventions and promote healthy living habits.
</description>
<dc:date>2014-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://elea.unisa.it/xmlui/handle/10556/1639">
<title>Resveratrol exerts no effect on inflammatory response and delayed onset muscle soreness after a marathon in male athletes. A randomised, double-blind, placebo-controlled pilot feasibility study</title>
<link>http://elea.unisa.it/xmlui/handle/10556/1639</link>
<description>Resveratrol exerts no effect on inflammatory response and delayed onset muscle soreness after a marathon in male athletes. A randomised, double-blind, placebo-controlled pilot feasibility study
Objective: We investigated whether the inflammatory response and delayed onset of muscle soreness after a marathon are altered by resveratrol, a natural polyphenolic flavonoid antioxidant.
Design: Double blind placebo-controlled randomised pilot study.
Setting: London Marathon.
Participants: Marathon race participants.
Interventions: 7 healthy male athletes were randomised to receive Resveratrol (600 mg Resveratrol daily for 7 days immediately before the marathon) or a placebo.
Main Outcome Measurements: Blood samples taken 48 hours before and 18-32 hours after the marathon were analysed for white blood cell count (WBC) and C-reactive protein (CRP). A VAS score was taken at the same times as the blood samples to assess delayed onset muscle soreness.
Results: There were no significant differences between the two groups in terms of changes occurring between pre- and post- tests for WBC, CRP or VAS.
Conclusions: There were no differences in immune response or delayed onset muscle soreness between resveratrol and placebo after a marathon. Further investigations are needed with longer treatment time and higher doses, analysing additional parameters such interleukins for a possible effect of resveratrol on the inflammatory response due to extensive exercise. To avoid a type II error, 17 subjects in each group would be required.
</description>
<dc:date>2014-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
